Foundries vs. Navigators: How AI Reshapes Scientific and Biotech Research Strategy
An essay published on Latent Space explores how the growing asymmetry between cheap AI-driven hypothesis generation ("thinking") and expensive physical experimentation ("doing") is driving biotech and scientific research into two organizational models: Foundries and Navigators. Foundries lower the cost of physical verification by industrializing lab measurements, while Navigators use advanced AI models to optimize decision-making without relying on proprietary wet labs. This structural framework explains how scientific startups can optimize capital allocation in an era where computational power is abundant but physical lab testing remains a bottleneck. It highlights a critical shift in biotech, showing that companies must either specialize in high-throughput automated data generation or excel at algorithmic navigation over existing scientific data. Foundries focus on scaling experimental throughput and developing novel instrumentation to generate proprietary datasets an order of magnitude faster and cheaper. Conversely, Navigators maximize capital efficiency by relying on open or pre-trained AI foundation models to skip massive lab infrastructure investments entirely.
## BACKGROUND
Traditional scientific R&D, especially in drug discovery and biotechnology, historically required massive upfront capital for physical laboratory experiments to validate candidate compounds. While recent breakthroughs in machine learning have vastly reduced the cost and time needed to simulate molecules and generate hypotheses, verifying these digital predictions in the real world remains costly and slow.